Lawrence Otto Klein Insider Trading $CRSP CRISPR Therapeutics AG
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Lawrence Otto Klein.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Lawrence Otto Klein. Lawrence Otto Klein is CBO & COO in CRISPR Therapeutics AG ($CRSP) and Chief Business Officer in CRISPR Therapeutics AG ($CRSP) and Director in Dyne Therapeutics, Inc. ($DYN).
Lawrence Otto Klein in CRISPR Therapeutics AG
Trading Symbol: CRSPIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Lawrence Otto Klein: CBO & COO, Chief Business Officer
Holdings: 25,050 shares
Current Value: $394,538
Latest Transaction: Mar 25 2021
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Lawrence Otto Klein in CRISPR Therapeutics AG
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 44.67 | 12,000 | 536,040 | 43,000 | |
Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 40.87 | 20,000 | 817,400 | 25,000 | |
Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 29.87 | 10,000 | 298,700 | 10,000 | |
Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 51.49 | 22,000 | 1,132,780 | 38,000 | |
Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 17.66 | 12,000 | 211,920 | 3,000 | |
Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 14.43 | 12,000 | 173,160 | 2,666 | |
Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 126.97 | 12,000 | 1,523,640 | 1,050 | 13.1 K to 1.1 K (-91.95 %) |
Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 128.20 | 88,000 | 11,281,600 | 13,050 | 101.1 K to 13.1 K (-87.09 %) |
Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 17.66 | 12,000 | 211,920 | 101,050 | 89.1 K to 101.1 K (+13.48 %) |
Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 14.43 | 12,000 | 173,160 | 89,050 | 77.1 K to 89.1 K (+15.57 %) |
Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 40.87 | 20,000 | 817,400 | 77,050 | 57.1 K to 77.1 K (+35.06 %) |
Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 29.87 | 10,000 | 298,700 | 57,050 | 47.1 K to 57.1 K (+21.25 %) |
Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 51.49 | 22,000 | 1,132,780 | 47,050 | 25.1 K to 47.1 K (+87.82 %) |
Mar 25 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 44.67 | 12,000 | 536,040 | 25,050 | 13.1 K to 25.1 K (+91.95 %) |
Mar 12 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Mar 12 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | A | 133.88 | 33,334 | 4,462,756 | 33,334 | |
Mar 12 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Payment of Exercise | F | 124.15 | 2,141 | 265,805 | 13,050 | 15.2 K to 13.1 K (-14.09 %) |
Mar 12 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 0.00 | 4,583 | 0 | 15,191 | 10.6 K to 15.2 K (+43.20 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 14.43 | 16,334 | 235,700 | 14,666 | |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 12.57 | 8,666 | 108,932 | 0 | |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 219.99 | 2 | 440 | 20,000 | 20 K to 20 K (-0.01 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 218.54 | 701 | 153,197 | 20,002 | 20.7 K to 20 K (-3.39 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 217.42 | 9,997 | 2,173,548 | 20,703 | 30.7 K to 20.7 K (-32.56 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 216.39 | 1,500 | 324,585 | 30,700 | 32.2 K to 30.7 K (-4.66 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 214.60 | 700 | 150,220 | 32,200 | 32.9 K to 32.2 K (-2.13 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 213.64 | 2,800 | 598,192 | 32,900 | 35.7 K to 32.9 K (-7.84 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 212.20 | 634 | 134,535 | 35,700 | 36.3 K to 35.7 K (-1.74 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 14.43 | 16,344 | 235,844 | 36,334 | 20 K to 36.3 K (+81.76 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 217.45 | 200 | 43,490 | 20,000 | 20.2 K to 20 K (-0.99 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 216.24 | 400 | 86,496 | 20,200 | 20.6 K to 20.2 K (-1.94 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 214.46 | 1,400 | 300,244 | 20,600 | 22 K to 20.6 K (-6.36 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 213.71 | 1,200 | 256,452 | 22,000 | 23.2 K to 22 K (-5.17 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 212.54 | 2,555 | 543,040 | 23,200 | 25.8 K to 23.2 K (-9.92 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 211.44 | 2,911 | 615,502 | 25,755 | 28.7 K to 25.8 K (-10.15 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 12.57 | 8,666 | 108,932 | 28,666 | 20 K to 28.7 K (+43.33 %) |
Jan 04 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Payment of Exercise | F | 153.11 | 9,392 | 1,438,009 | 10,608 | 20 K to 10.6 K (-46.96 %) |
Oct 06 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | A | 86.75 | 16,666 | 1,445,776 | 16,666 | |
Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 12.57 | 4,912 | 61,744 | 8,666 | |
Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 12.57 | 26,422 | 332,125 | 13,578 | |
Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 5.86 | 38,666 | 226,583 | 0 | |
Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 75.18 | 4,912 | 369,272 | 20,000 | 24.9 K to 20 K (-19.72 %) |
Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 12.57 | 4,912 | 61,744 | 24,912 | 20 K to 24.9 K (+24.56 %) |
Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 76.26 | 2,913 | 222,138 | 20,000 | 22.9 K to 20 K (-12.71 %) |
Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 75.32 | 12,175 | 917,054 | 22,913 | 35.1 K to 22.9 K (-34.70 %) |
Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 76.50 | 800 | 61,201 | 35,088 | 35.9 K to 35.1 K (-2.23 %) |
Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 75.94 | 3,934 | 298,736 | 35,888 | 39.8 K to 35.9 K (-9.88 %) |
Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 74.90 | 6,600 | 494,323 | 39,822 | 46.4 K to 39.8 K (-14.22 %) |
Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 12.57 | 26,422 | 332,125 | 46,422 | 20 K to 46.4 K (+132.11 %) |
Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 76.50 | 22,700 | 1,736,575 | 20,000 | 42.7 K to 20 K (-53.16 %) |
Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 75.93 | 15,966 | 1,212,265 | 42,700 | 58.7 K to 42.7 K (-27.22 %) |
Jun 26 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 5.86 | 38,666 | 226,583 | 58,666 | 20 K to 58.7 K (+193.33 %) |
May 13 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 5.86 | 25,000 | 146,500 | 38,666 | |
May 13 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 61.07 | 682 | 41,650 | 20,000 | 20.7 K to 20 K (-3.30 %) |
May 13 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 60.38 | 24,318 | 1,468,321 | 20,682 | 45 K to 20.7 K (-54.04 %) |
May 13 2020 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 5.86 | 25,000 | 146,500 | 45,000 | 20 K to 45 K (+125.00 %) |
Dec 05 2019 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | Chief Business Offi ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Sep 12 2019 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | Chief Business Offi ... | Option Exercise | A | 0.00 | 10,000 | 0 | 30,000 | |
Jul 12 2019 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | Chief Business Offi ... | Option Exercise | M | 5.86 | 8,421 | 49,347 | 63,666 | |
Jul 12 2019 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | Chief Business Offi ... | Option Exercise | M | 5.86 | 11,579 | 67,853 | 72,087 | |
Jul 12 2019 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | Chief Business Offi ... | Sell | S | 50.01 | 8,421 | 421,171 | 20,000 | 28.4 K to 20 K (-29.63 %) |
Jul 12 2019 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | Chief Business Offi ... | Buy | M | 5.86 | 8,421 | 49,347 | 28,421 | 20 K to 28.4 K (+42.11 %) |
Jul 12 2019 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | Chief Business Offi ... | Sell | S | 50.02 | 11,579 | 579,182 | 20,000 | 31.6 K to 20 K (-36.67 %) |
Jul 12 2019 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | Chief Business Offi ... | Buy | M | 5.86 | 11,579 | 67,853 | 31,579 | 20 K to 31.6 K (+57.90 %) |
Mar 07 2019 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | Chief Business Offi ... | Option Exercise | A | 40.87 | 45,000 | 1,839,150 | 45,000 |
Page: 1